Back to mobile site

Leerink Partners Reiterates Outperform Rating on Cardinal Health (CAH): "company is set up for solid FY2H'26 growth"

March 9, 2026 1:22 PM EDT Send to a Friend
Leerink Partners analyst Michael Cherny reiterated an Outperform rating and $275.00 price target on Cardinal Health (NYSE: CAH)The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login